Skip to main content
. 2020 Dec 31;151(2):303–311. doi: 10.1093/jn/nxaa374

TABLE 4.

HRs (95% CIs) for incident type 2 diabetes and cardiovascular disease according to metabolites correlated with walnut consumption in the PREDIMED study1

PREDIMED study baseline2 PREDIMED year 13
HR (95% CI) P HR (95% CI) P
Type 2 diabetes
 No. of cases/total participants 245/923 161/704
 Score of metabolites predicting walnuts
  Model 1 (basic model) 0.82 (0.72, 0.94) 0.005 0.76 (0.63, 0.91) 0.004
  Model 2 (+ sociodemographic model) 0.86 (0.74, 0.99) 0.04 0.80 (0.64, 0.99) 0.044
  Model 3 (+ diet model) 0.86 (0.74, 1.00) 0.05 0.82 (0.64, 1.05) 0.125
  Model 4 (+ consumption of walnuts) 0.83 (0.71, 0.97) 0.02 0.81 (0.63, 1.03) 0.092
Cardiovascular disease
 No. of cases/total participants 222/993 159/916
  Model 1 (basic model) 0.72 (0.63, 0.84) <0.001 0.74 (0.62, 0.88) <0.001
  Model 2 (+ sociodemographic model) 0.67 (0.58, 0.78) <0.001 0.76 (0.62, 0.92) 0.007
  Model 3 (+ diet model) 0.66 (0.56, 0.77) <0.001 0.75 (0.60, 0.93) 0.011
  Model 4 (+ consumption of walnuts) 0.71 (0.60, 0.85) <0.001 0.76 (0.61, 0.95) 0.016

1Model 1 (basic model): adjusted for age, sex, and propensity scores; stratified by intervention group and recruitment center. Model 2 (sociodemographic model): model 1 + BMI, smoking status (never, former, or current smoker), alcohol intake and squared alcohol intake (grams per day), education level (primary, secondary, academic), physical activity (metabolic-equivant minutes per day), family history of CHD (yes/no), baseline dyslipidemia or lipid-lowering medication use (yes/no), baseline hypertension or antihypertensive use (yes/no), and T2D prevalence (only in CVD analysis). Model 3: model 2 + total energy and intakes of vegetables, fruits, cereals, red and processed meat, fish, olive oil, eggs, legumes, and dairy in quintiles. Model 4: model 3 + intake of walnuts from which metabolite set was derived. CHD, coronary heart disease; CVD, cardiovascular disease; PREDIMED, PREvención con DIeta MEDiterránea; T2D, type 2 diabetes.

2Analysis of CVD risk was conducted among the 993 participants of the PREDIMED CVD case–cohort data set or 923 in the T2D case–cohort data set. Cox proportional hazard models, with Barlow weights (inverse probability weights to account for the overrepresentation of cases), were used to estimate HRs and their 95% CIs for risk of CVD. Person-time of follow-up was calculated as the interval between the baseline date and date of CVD or T2D event, death, or date of the last participant contact, whichever came first. HRs refer to 1-SD increase in correlated multimetabolite score.

3Walnuts intake, metabolic signatures, and covariates were assessed at year 1, and outcome was the incident CVD events occurred after the year 1 visit through the end of follow-up. The analytic models were the same as in the baseline analysis. A total of 916 participants were included in the CVD analyses and 704 in the T2D analyses.